Renal Interventions
@Renal_Ints
Followers
922
Following
318
Media
369
Statuses
1K
#Renal Interventions is a specialised digital publication providing news and insight to a multidisciplinary audience in the #kidney care field.
London, UK
Joined February 2021
The #CX2025 audience agrees with Garnham’s assertion that vascular access training IS inadequate
0
0
1
Frank Dor and Andrew Garnham debate whether current vascular access training is adequate #CX2025
1
2
3
.@robshahverdyan offers an update on endoAVF trials, acknowledging that challenges now exist with the impending withdrawal of Ellipsys from the market #CX2025
0
1
3
Karen Stevenson sets out information needs for clinicians and patients in vascular access #CX2025
1
0
1
Nicholas Inston opens the Vascular Access Masterclass at #CX2025, setting the scene for the day’s session which will probe vascular access challenges, and the need to find the right access, for the right patient at the right time
1
1
1
RT @VascularNews: "I'm very intrigued by what's going on in xenotransplantation". Bart Dolmatch looks ahead to the future of care for #haem….
0
2
0
RT @VascularNews: “I think we keep our eyes on the evolution of the treatment algorithm”. Kate Steiner outlines future priorities in #Vascu….
0
2
0
RT @VascularNews: Are we on the cusp of pharmacological management for AV fistulas?. @nick_inston shares what #VascularAccess data he looks….
0
2
0
RT @VascularNews: Great to speak with Maarten Snoeijs at #EVC2025 to discuss this year’s vascular access programme at the meeting as well a….
0
1
0
.@medibeacon has won FDA approval for the MediBeacon TGFR system for the assessment of kidney function in patients with normal or impaired renal function. TGFR uses an intravenous Lumitrace injection but does not require blood draws or urine analysis.
0
1
3
Centers for Medicare & Medicaid Services is opening a national coverage analysis on renal denervation, with a view to reviewing and developing a national Medicare coverage policy for the therapy for patients with hypertension @Medtronic @ReCorMedical.
0
0
0
As a part of the 2024 @VEITHsymposium, @DillavouEllen presented new data about the SelfWrap (VenoStent) bioabsorbable perivascular wrap, outlining how the novel device can, in her words, improve arteriovenous fistula (AVF) maturation and patency
0
0
1
At @VEITHsymposium 2024, Robert E Lee, a medical officer recently retired from the @US_FDA, presented his argument for when the use of RCTs for the regulation and approval of novel vascular access devices becomes important
0
0
0
.@RevBio1 recently announced that the US FDA has accepted its investigational new drug (IND) application for Gemini
0
0
0
.@RockwellMedical, a healthcare company that develops, manufactures, commercialises, and distributes a portfolio of haemodialysis products to dialysis providers worldwide, today announced that Jesse Neri was promoted to chief financial officer (CFO)
0
0
0
New research recently published in @LancetLongevity suggest that post-operative diet and exercise guidance can be beneficial for #HRQoL in patients that have received a kidney transplant, but that maintaining these improvements can prove to be challenging
0
0
0
#VEITH24: Mahmood Razavi delivers six-month data from the Wrapsody AV access cell-permeable endoprothesis pivotal trial, specifically on the AV graft anastomosis cohort for the first time. @VEITHsymposium
0
0
0
#VEITH24: C. Keith Ozaki delivers data from RCT comparing Humacyte tissue-engineered vessel vs. autologous AV fistula in end-stage renal patients. @VEITHsymposium
0
1
13
#VEITH24: Studies of HemoWrap device for post-cannulation hemostasis show it is safe and effective and has high patient satisfaction, says Sundaram Ravikumar. @VEITHsymposium
0
0
0
#VEITH24: @DillavouEllen details use of the SelfWrap device (VenoStent), designed to improve AV fistula outcomes, and latest trial data.
0
1
4